Equities

Climb Bio Inc

CLYM:NMQ

Climb Bio Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)3.53
  • Today's Change-0.270 / -7.11%
  • Shares traded211.04k
  • 1 Year change+37.35%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast

The 2 analysts offering 12 month price targets for Climb Bio Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 4.00. The median estimate represents a 27.48% increase from the last price of 3.53.
High41.6%5.00
Med27.5%4.50
Low13.3%4.00

Earnings history & estimates in USD

Annual earnings information is not available for Climb Bio Inc.
Average growth rate+59.43%
More ▼

Revenue history & estimates in USD

Annual revenue information is not available for Climb Bio Inc.
Average growth rate0.00%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.